SCM
FHTX icon

Sio Capital Management’s Foghorn Therapeutics FHTX Stock Holding History

Sio Capital Management’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-122,889
Closed -$587K – 73
2026
Q1 		$587K Hold
122,889
– – 0.08% 63
2025
Q4 		$664K Hold
122,889
– – 0.1% 59
2025
Q3 		$601K Hold
122,889
– – 0.15% 43
2025
Q2 		$578K Buy
122,889
+1,217
+1% +$5.09K 0.22% 42
2025
Q1 		$444K Hold
121,672
– – 0.13% 47
2024
Q4 		$574K Hold
121,672
– – 0.16% 40
2024
Q3 		$1.13M Hold
121,672
– – 0.45% 26
2024
Q2 		$700K Hold
121,672
– – 0.19% 40
2024
Q1 		$816K Hold
121,672
– – 0.24% 43
2023
Q4 		$785K Buy
+121,672
New +$525K 0.18% 34

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Sio Capital Management's FHTX Position: Q2 2026 in Review

Sio Capital Management sold out of Foghorn Therapeutics (FHTX) in Q2 2026, closing a stake of 122,889 shares — an estimated $587K sold.

Sio Capital Management first reported a position in FHTX in Q4 2023 and held it in 10 quarters. The position peaked at $1.13M in Q3 2024. 103 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Sio Capital Management reported no remaining Foghorn Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Sio Capital Management sold 122,889 Foghorn Therapeutics shares in Q2 2026, an estimated $587K.
  • Sio Capital Management first reported a position in Foghorn Therapeutics in Q4 2023 and held it in 10 quarters.
  • Sio Capital Management's Foghorn Therapeutics position peaked at $1.13M in Q3 2024.
  • 103 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.